Evidence map›Paper›PMID 36318373›Full record

ArticleArchives of osteoporosis2022

Spanish National Registry of Major Osteoporotic Fractures (REFRA) seen at Fracture Liaison Services (FLS): objectives and quality standards.

Maria Jose Montoya-Garcia, Cristina Carbonell-Abella, Jose Manuel Cancio-Trujillo, Maria Jesus Moro-Álvarez, Jesus Mora-Fernández, Rafael Izquierdo-Avino, Xavier Nogues, Manuel Mesa-Ramos, Rosa Maria San Segundo-Mozo, Elena Calero-Muñoz and 4 more

Abstract read
In one paragraph

Article in Archives of osteoporosis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Examining treatment targets and equity in bone-active medication use within secondary fracture prevention: a systematic review and meta-analysis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2024
    Pooled it
  2. Article
  3. Article
  4. Adequacy of pharmacological prescription in patients at very high risk of fracture within the FLS in Spain: analysis of the REFRA FLS-SEIOMM Registry.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Observational
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Maria Jose Montoya-Garcia *Departamento de Medicina, Universidad de Sevilla, Hospital Universitario Virgen Macarena, Sevilla, Spain. pmontoya@us.es.ORCID http://orcid.org/0000-0002-4946-6667
Cristina Carbonell-Abella *Centro de Salud Via Roma ICS Barcelona, Universidad de Barcelona, Barcelona, Spain. ccarbonell@ub.edu.ORCID http://orcid.org/0000-0002-9831-9890
Jose Manuel Cancio-TrujilloDepartament of Geriatric Medicine and Palliative Care, Badalona Serveis Assistencials, Badalona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-8437-2607
Maria Jesus Moro-ÁlvarezSección Medicina Interna Hospital Central Cruz Roja San José Y Santa Adela, Madrid, Spain.
Jesus Mora-FernándezInstituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Universidad Complutense, Madrid, Spain.ORCID http://orcid.org/0000-0001-6082-6208
Rafael Izquierdo-AvinoDepartmento de Traumatologia Y Ortopedia, Hospital Nuestra Señora de Gracia, Zaragoza, Spain.ORCID http://orcid.org/0000-0001-9654-8801
Xavier NoguesIMIM (Hospital del Mar Medical Research Institute), Centro de Investigación Biomédica en Red de Fragilidad Y Envejecimiento Saludable (CIBERFES), 08003, Barcelona, Spain.ORCID http://orcid.org/0000-0002-5537-1859
Manuel Mesa-RamosHospital Valle de los Pedroches, Pozoblanco, Córdoba, Spain.ORCID http://orcid.org/0000-0001-8776-2363
Rosa Maria San Segundo-MozoUniversitat Rovira I Virgili, Tarragona, Spain.ORCID http://orcid.org/0000-0001-7420-2914
Elena Calero-MuñozXarxa Sanitària, Social I Docent Santa Tecla, Tarragona, Spain.ORCID http://orcid.org/0000-0002-5557-0698
Manuel Naves-DiazHospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.ORCID http://orcid.org/0000-0003-0323-2870
F Jesus Olmo-MontesUnidad de Metabolismo Óseo, Hospital Universitario Virgen Macarena, Sevilla, Spain.ORCID http://orcid.org/0000-0002-0756-7670
Enric DuasoHospital Universitari d'Igualada, FLS Anoia, Igualada, Barcelona, Spain.ORCID http://orcid.org/0000-0002-8593-5977
GRUPO REFRA-FLS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

REFRA-FLS is a new registry in Spain aimed at identifying individuals over 50 years of age with a fragility fracture. Using this registry, we found hip fracture is the most prevalent fracture. Treatment for osteoporosis was 87.7%, with 65.3% adherence. REFRA-FLS provides fundamental data in the study of fragility fractures. PURPOSE: Fragility fractures are a growing public health concern in modern-aged societies. Fracture Liaison Services (FLS) have been shown to successfully lower rates of secondary fractures. A new registry (REFRA-FLS) has been created to monitor quality indicators of FLS units in Spain and to explore the occurrence and characteristic of fragility fractures identified by these centers.

methodsWe conducted a prospective cohort study based on fragility fractures recorded in the REFRA-FLS registry. Participants were individuals 50 years or above who suffered a low energy fragility fracture identified by the 10 participating FLS units during the study period. The type of FLS unit, the characteristics of the individuals at baseline, along with patient outcomes as quality indicators among those who completed 1 year of follow-up were analyzed.

resultsA total of 2965 patients and 3067 fragility fractures were identified, and the most frequent locations were hip (n = 1709, 55.7%) and spine (n = 492, 16.0%). A total of 43 refractures (4.5%) and 46 deaths (4.9%) were observed among 948 individuals in the follow-up analyses. Time from fracture to evaluation was less than 3 months in 76.7% of individuals. Osteoporosis treatment was prescribed in 87.7%, and adherence was 65.3% in Morisky-Green test.

conclusionOur results provide a comprehensive picture of fragility fractures identified in FLS units from Spain. Overall, quality indicators are satisfactory although a much higher use of DXA would be desirable. As the registry grows with the incorporation of new FLS units and longer follow-up, incoming analyses will provide valuable insight.

Indexed as

Bone Density Conservation AgentsOsteoporosisOsteoporotic FracturesAgedHumansMiddle AgedProspective StudiesRegistriesBone Density Conservation AgentsAdherenceFracture Liaison ServicesFragility fracturesOsteoporosis

Identifiers

PMID36318373
PMCPMC9626427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.